Despite a large number of neuroimaging studies in schizophrenia reporting subtle brain abnormalities, we do not know to what extent such abnormalities reflect the effects of antipsychotic treatment on brain structure. We therefore systematically reviewed cross-sectional and follow-up structural brain imaging studies of patients with schizophrenia treated with antipsychotics. 30 magnetic resonance imaging (MRI) studies were identified, 24 of them being longitudinal and six cross-sectional structural imaging studies. In patients with schizophrenia treated with antipsychotics, reduced gray matter volume was described, particularly in the frontal and temporal lobes. Structural neuroimaging studies indicate that treatment with typical as well as atypical antipsychotics may affect regional gray matter (GM) volume. In particular, typical antipsychotics led to increased gray matter volume of the basal ganglia, while atypical antipsychotics reversed this effect after switching. Atypical antipsychotics, however, seem to have no effect on basal ganglia structure. © 2009 Bentham Science Publishers Ltd.

The effects of antipsychotics on the brain: What have we learnt from structural imaging of schizophrenia? - A systematic review

Fusar-Poli P.;
2009-01-01

Abstract

Despite a large number of neuroimaging studies in schizophrenia reporting subtle brain abnormalities, we do not know to what extent such abnormalities reflect the effects of antipsychotic treatment on brain structure. We therefore systematically reviewed cross-sectional and follow-up structural brain imaging studies of patients with schizophrenia treated with antipsychotics. 30 magnetic resonance imaging (MRI) studies were identified, 24 of them being longitudinal and six cross-sectional structural imaging studies. In patients with schizophrenia treated with antipsychotics, reduced gray matter volume was described, particularly in the frontal and temporal lobes. Structural neuroimaging studies indicate that treatment with typical as well as atypical antipsychotics may affect regional gray matter (GM) volume. In particular, typical antipsychotics led to increased gray matter volume of the basal ganglia, while atypical antipsychotics reversed this effect after switching. Atypical antipsychotics, however, seem to have no effect on basal ganglia structure. © 2009 Bentham Science Publishers Ltd.
2009
Inglese
15
22
2535
2549
15
Antipsychotics; Atypical neuroleptics; Conventional; MRI; Neuroimaging; Schizophrenia; Typical; Antipsychotic Agents; Brain; Clinical Trials as Topic; Humans; Magnetic Resonance Imaging; Schizophrenia
http://docserver.ingentaconnect.com/deliver/connect/ben/13816128/v15n22/s2.pdf?expires=1250538681&id=51648145&titleid=3901&accname=Elsevier+Bibliographic+Databases&checksum=3A64561EBFA7E923CBAC46404DB20ECE
10
info:eu-repo/semantics/article
262
Smieskova, R.; Fusar-Poli, P.; Allen, P.; Bendfeldt, K.; Stieglitz, R. D.; Drewe, J.; Radue, E. W.; Mcguire, P. K.; Riecher-Rossler, A.; Borgwardt, S....espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1313616
Citazioni
  • ???jsp.display-item.citation.pmc??? 80
  • Scopus 188
  • ???jsp.display-item.citation.isi??? 181
social impact